Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2018
Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS), also known as Chronic Fatigue Syndrome (CFS), involves severe fatigue and neurological issues due to immune system dysfunction. Treatments are varied and not consistently effective, highlighting the complexity of this condition.
Area of Science:
Immunology
Neurology
Infectious Disease Epidemiology
Context:
Chronic Fatigue and Immune Dysfunction Syndrome (CFIDS), also known as Chronic Fatigue Syndrome (CFS), is a complex, debilitating condition with diverse symptoms.
CFIDS symptoms can mimic other serious illnesses, including mononucleosis, multiple sclerosis, fibromyalgia, and autoimmune diseases like lupus.
The condition affects all populations but appears most prevalent in women under 45.
Purpose:
To describe the characteristics of CFIDS, including its varied nomenclature (e.g., Myalgic Encephalomyelitis/CFS).
To explore the proposed underlying cause of CFIDS as immune system dysfunction.
To review the current landscape of treatment options and their varying efficacy.
Summary:
CFIDS is characterized by incapacitating fatigue, neurological problems, and a wide range of symptoms that fluctuate in severity and duration.
Investigative findings suggest CFIDS stems from immune system dysfunction, potentially an overactive or unregulated state, with some evidence of immune suppression.
Current treatments, including psychotherapy, physiotherapy, exercise, acupuncture, and antidepressants, offer limited and inconsistent success.
Impact:
Highlights the need for further research into the precise mechanisms of immune dysfunction in CFIDS.
Informs patients and healthcare providers about the multifaceted nature of CFIDS and the challenges in management.
Underscores the importance of recognizing CFIDS as a distinct syndrome with significant impact on quality of life.